Atlas Venture Associates X, LLC - Insider Non-Derivative Transactions at Kymera Therapeutics, Inc. (KYMR) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 13, 2024, Atlas Venture Associates X, LLC's relationship to Kymera Therapeutics, Inc. (KYMR) is TenPercentOwner, and currently has 4,682,761 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KYMR insiders.

Data Source: SEC.
Atlas Venture Associates X, LLC - Insider Non-Derivative Transactions of KYMR Common Stock
Atlas Venture Associates X, LLC - Insider Non-Derivative Transactions at KYMR
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 14, 2024 Sell -- (Common Stock) 1386 42.84 828830
Mar 14, 2024 Sell -- (Common Stock) 22779 42.19 830216
Mar 14, 2024 Sell -- (Common Stock) 6686 42.84 4676075
Mar 14, 2024 Sell -- (Common Stock) 108404 42.19 4682761
Mar 13, 2024 Sell -- (Common Stock) 1819 42.52 852995
Mar 13, 2024 Sell -- (Common Stock) 26452 41.94 854814
Mar 13, 2024 Sell -- (Common Stock) 8581 42.52 4791165
Mar 13, 2024 Sell -- (Common Stock) 126066 41.94 4799746
Mar 12, 2024 Sell -- (Common Stock) 1045 43.42 881266
Mar 12, 2024 Sell -- (Common Stock) 7837 42.77 882311
Mar 12, 2024 Sell -- (Common Stock) 5122 43.42 4925812
Mar 12, 2024 Sell -- (Common Stock) 37180 42.77 4930934
Jan 13, 2023 Sell -- (Common Stock) 21592 30.29 890148
Jan 13, 2023 Sell -- (Common Stock) 77128 30.29 4968114
Jan 12, 2023 Sell -- (Common Stock) 6071 29.96 911740
Jan 12, 2023 Sell -- (Common Stock) 21683 29.96 5045242